Ignite Creation Date:
2024-05-11 @ 8:28 AM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06399848
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-05-06
First Post:
2024-04-28
Brief Title:
Peritoneal Dialysis Daily Versus Six Days Per Week
Sponsor:
Stanford University
Organization:
Stanford University
Study Overview
Official Title:
Peritoneal Dialysis Daily Versus Six Days Per Week
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The study will enroll patients receiving daily peritoneal dialysis who have significant residual native kidney function The investiators will visit the patients at a routinely scheduled clinic visit and again at a non-routine visit after the patients skip a single day of dialysis Blood samples will be obtained and a quality of life questionnaire will be administered at both visits
The primary aim will be to determine whether the patients would prefer daily treatment or being allowed to skip one day per week
Other aims will be to determine the effect of skipping a day on plasma levels of urea nitrogen and creatinine
The primary aim will be to determine whether the patients would prefer daily treatment or being allowed to skip one day per week
Other aims will be to determine the effect of skipping a day on plasma levels of urea nitrogen and creatinine
Detailed Description:
The patients preference will be assessed by asking the simple question would you prefer to perform peritoneal dialysis daily of six days per week
The quality of life questionnaire to be used will be the Dialysis Symptom Index DSI which has a range of 0 to 150 with a high score reflecting worse quality of life
The chemical to be measured will be the plasma urea nitrogen in mgdl and the plasma creatinine in mgdl as measured by the clinical laboratory
The quality of life questionnaire to be used will be the Dialysis Symptom Index DSI which has a range of 0 to 150 with a high score reflecting worse quality of life
The chemical to be measured will be the plasma urea nitrogen in mgdl and the plasma creatinine in mgdl as measured by the clinical laboratory
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None